Stay updated on ProstAtak Immunotherapy in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ProstAtak Immunotherapy in Prostate Cancer Clinical Trial page.

Latest updates to the ProstAtak Immunotherapy in Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check30 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record. The site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check44 days agoChange DetectedA new version of the prostate cancer clinical trial record was submitted on September 30, 2026, updating its study status and contact or location information.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, signaling a platform release. This change does not modify the study's data or history content.SummaryDifference0.0%

- Check79 days agoChange DetectedA new revision (v3.6.6) was added to the record history, superseding v3.6.5. This indicates a page update for tracking purposes rather than a substantive change to trial information.SummaryDifference0.0%

Stay in the know with updates to ProstAtak Immunotherapy in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ProstAtak Immunotherapy in Prostate Cancer Clinical Trial page.